Construction of Injectable Tetra-Polyethylene Glycol Hydrogel Adhesive for Wound Healing
Highlights in Science, Engineering and Technology · 17.04.2026 · 162 · 394-400
DOI: 10.54097/0g88kc93 ↗Kurz gefasst
Fachartikel in der Zeitschrift Highlights in Science, Engineering and Technology, online erschienen am 17.04.2026. Verfasst von Qirui Wang. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Wundversorgung
Abstract (Originalsprache)
Hydrogel wound dressings are medical materials that accelerate wound healing by maintaining a moist environment, promoting tissue repair, and absorbing exudate. Its core efficacy is based on the material's high-water content (typically 60%-90%) and biocompatibility, which can provide ideal repair conditions for wounds while reducing the risk of complications. In this work, we constructed a class of tetra-polyethylene glycol hydrogel systems based on rapid chemical reactions, with a fast gelation rate, significant mechanical strength, and sufficient adhesion. Cytotoxicity tests demonstrated that the hydrogels had good biocompatibility, the hydrogel adhesives did not cause secondary damage to the surrounding tissues, and could promote tissue repair and regeneration, providing ideas for the development of a new generation of bioadhesives.
Zitieren
APA
Wang, Q. (2026). Construction of Injectable Tetra-Polyethylene Glycol Hydrogel Adhesive for Wound Healing. Highlights in Science, Engineering and Technology, 162, 394-400. https://doi.org/10.54097/0g88kc93
Vancouver
Wang Q. Construction of Injectable Tetra-Polyethylene Glycol Hydrogel Adhesive for Wound Healing. Highlights in Science, Engineering and Technology. 2026;162:394-400. doi:10.54097/0g88kc93
BibTeX
@article{Wang2026,
author = {Wang, Qirui},
title = {Construction of Injectable Tetra-Polyethylene Glycol Hydrogel Adhesive for Wound Healing},
journal = {Highlights in Science, Engineering and Technology},
year = {2026},
volume = {162},
pages = {394--400},
doi = {10.54097/0g88kc93}
}
EUVIMED